Pappas Ventures

Pappas Ventures

Pappas Ventures

Life science - focused venture capital firm.
Founded
1994
Follow us
Pulse 2.0

Kezar Life Sciences (KZR) Stock: Why The Price Surged Today

$45,000,000 Venture capital (Series D)
Pulse 2.0

Evidation Health: $45 Million Funding And Sam Marwaha Joins As Chief Commercial Officer

FinSMEs

Evidation Health Raises $45M in Series D Funding

Xconomy

Grail Plants a Seed in RTP, Pledges $100M Investment in New Site

PE HUB

GSK slides after buying cancer firm Tesaro for hefty $5.1 billion: Reuters

MedCity News

GlaxoSmithKline to buy cancer-focused Tesaro for $5.1 billion

$30,000,000 Venture capital (Series C)
PE HUB

Evidation Health scores $30 mln Series C

Messaging
FinSMEs

Evidation Health Raises $30M in Series C Venture Capital Funding

Health Funding Cloud
$75,000,000 IPO
PE HUB

VC-backed Kezar Life Sciences unveils IPO

Stock markets Health
PE HUB

| Pappas Capital sells Rotation Medical to Smith & Nephew

Funding Health
PE HUB

Smith & Nephew to buy Rotation Medical for up to $210 mln: Reuters

Strategy
$10,000,000 Venture capital
PE HUB

Evidation Health takes in $10 mln

Data leaks Funding
Xconomy

Manufacturing Issues Stall Tesaro Cancer Nausea Drug at FDA

Robotics Health
$3,400,000 Venture capital (Series B)
mobihealthnews , vcaonline

Evidation Health adds another $3.4 million from Facebook cofounder's VC firm

$12,000,000 Venture capital (Series B)
FinSMEs

Rotation Medical Raises $12M Series B Financing

Funding Health
Xconomy

Tesaro Stock Sale Hauls in $409M on Heels of Strong Cancer Data

Health
The Motley Fool

Why Achillion Pharmaceuticals Is Down Big in 2016

$11,600,000 Venture capital (Series B)
BioPortfolio

Evidation Health raises $11.6M, adds backing from Facebook co-founder’s B Capital Group fund

Health
The Motley Fool

Why Achillion Pharmaceuticals Jumped 10% in May

Xconomy

Chimerix, TransEnterix, BDSI, Duke Energy & More NC Innovation News

Health